Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome
An Open Label Study to Evaluate the Long-term Safety and Efficacy of Odevixibat (A4250) in Patients with Alagille Syndrome (ASSERT-EXT). Detailed Description: Approximately 35 sites will be initiated for this study in North America, Europe, Middle East, and Asia Pacific.
Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome
- 26 September 2024 - 1 mins read
An Open Label Study to Evaluate the Long-term Safety and Efficacy of Odevixibat (A4250) in Patients with Alagille Syndrome (ASSERT-EXT). Detailed Description: Approximately 35 sites will be initiated for this study in North America, Europe, Middle East, and Asia Pacific.
Related Clinical Trials
26 September 2024
1 mins read
Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis
26 September 2024
1 mins read
Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In Children
26 September 2024
1 mins read
Dysport® Adult Upper Limb Spasticity Extension Study
26 September 2024
1 mins read
Safety and Efficacy Study of Dysport RU and Glabellar Lines
26 September 2024
1 mins read
Dysport® Adult Upper Limb Spasticity
26 September 2024
1 mins read
Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical...
26 September 2024
1 mins read
Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment
26 September 2024
1 mins read
Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
26 September 2024
1 mins read
Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome
26 September 2024
1 mins read